SLS — SELLAS Life Sciences Group, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on SLS
| date | signal | measured base rate |
|---|---|---|
| 2026-08-21 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-07-28 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-06-26 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-05-29 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
| 2026-05-15 | Institutional holders jumped in a quarter ownership | -0.52% over 21 days · t = -0.38 · n = 1,553 not distinguishable from its control group |
| 2026-05-13 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-16 | Stergiou Angelos M. President and CEO | Grant or award | 1.1M | 0.00 | 0 |
| 2026-01-07 | Kalin Katherine Bach Director | Grant or award | 50.0K | 0.00 | 0 |
| 2026-01-07 | VAN NOSTRAND ROBERT L Director | Grant or award | 50.0K | 0.00 | 0 |
| 2026-01-07 | Wasman Jane Director | Grant or award | 50.0K | 0.00 | 0 |
| 2026-01-07 | Burns John Thomas CFO | Grant or award | 300.0K | 0.00 | 0 |
| 2026-01-07 | SCHEINBERG DAVID A Director | Grant or award | 50.0K | 0.00 | 0 |
| 2026-01-07 | Varian John Director | Grant or award | 50.0K | 0.00 | 0 |
| 2026-01-07 | CICIC DRAGAN SVP, Chief Development Officer | Grant or award | 300.0K | 0.00 | 0 |
| 2025-12-03 | Stergiou Angelos M. President and CEO | Other Acquisition/Disposition | 187.1K | 1.50 | 280.6K |
| 2025-12-03 | CICIC DRAGAN SVP, Chief Development Officer | Other Acquisition/Disposition | 63.8K | 1.50 | 95.7K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 51.6M | 12.2M |
| STATE STREET CORP | 35.5M | 8.4M |
| VANGUARD CAPITAL MANAGEMENT LLC | 31.8M | 7.5M |
| GEODE CAPITAL MANAGEMENT, LLC | 16.6M | 3.9M |
| MARSHALL WACE, LLP | 8.6M | 2.0M |
| JONES FINANCIAL COMPANIES LLLP | 7.3M | 1.7M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.2M | 1.5M |
| MORGAN STANLEY | 5.7M | 1.3M |
| NORTHERN TRUST CORP | 5.4M | 1.3M |
| VANGUARD FIDUCIARY TRUST CO | 5.1M | 1.2M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- 10 Health Care Stocks Whale Activity In Today’s Session · 2026-08-21 · benzinga
- 10 Health Care Stocks Whale Activity In Today’s Session · 2026-08-18 · benzinga
- Sellas Life Sciences Group, Inc. (SLS) filed form 8-K · 2026-08-11 · SEC EDGAR
Ask the AI about SLS
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →